Exhibit 240 ยท Clinical practice guideline
AAN/ACR/IDSA 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease
For patients who have persistent or recurring nonspecific symptoms such as fatigue, pain, or cognitive impairment following recommended treatment for Lyme disease, but who lack objective evidence of reinfection or treatment failure, we recommend against additional antibiotic therapy
Section XXV distinguishes persistent nonspecific symptoms from objective evidence of reinfection or treatment failure in its recommendation against additional antibiotics.
- Source
- IDSA, American Academy of Neurology, American College of Rheumatology
- Date
- 30 November 2020
- Quoted from
- Recommendation XXV
- Grade
- Primary record
- Document
- https://www.idsociety.org/practice-guideline/lyme-disease/
- Accessed
- 2026-11-09
- Cited by
- Findings citing this exhibit